16.12.2012 Views

24/06/2005 - Controller General of Patents, Designs, and Trade Marks

24/06/2005 - Controller General of Patents, Designs, and Trade Marks

24/06/2005 - Controller General of Patents, Designs, and Trade Marks

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

(12) PATENT APPLICATION PUBLICATION<br />

(19)<br />

INDIA (21) Application No: 407/MUMNP/2004 A<br />

(22) Date <strong>of</strong> filing <strong>of</strong> Application : 26/07/2004<br />

(54) Title <strong>of</strong> the invention:<br />

(51) International Classification: C 07 D 471/10 (71)<br />

(31) Priority Document No. : 60/344,750<br />

(32) Priority Date :<br />

(33) Name <strong>of</strong> priority country :<br />

(86)<br />

(43) Publication Date: <strong>24</strong>/<strong>06</strong>/<strong>2005</strong><br />

SPIROAZACYCLIC COMPOUNDS AS MONOAMINE RECEPTOR<br />

MODULATORS.<br />

28/12/2001<br />

U.S.A.<br />

International Application : PCT/US02/41476<br />

No. <strong>and</strong> Filing Date : 23/12/2002<br />

(87) International :<br />

Publication No. WO03/057698 A2<br />

(61)<br />

(62)<br />

Patent <strong>of</strong> addition to<br />

Application No. : NIL<br />

Filed on N.A.<br />

Divisional to<br />

Application No. : NIL<br />

Filed on : N.A.<br />

(72)<br />

Name <strong>of</strong> the Applicant:<br />

ACADIA PHARMACEUTICALS INC<br />

Address <strong>of</strong> the Applicant:<br />

3911 SORRENTO VALLEY BLVD.,<br />

SAN DIEGO, CA 92121-1402,<br />

UNITED STATES OF AMERICA.<br />

Name <strong>of</strong> the Inventors:<br />

SCHLIENGER NATHALIE<br />

Filed U/S 5(2) before the<br />

<strong>Patents</strong> (Amendment)<br />

Ordinance,2004 : NO<br />

(57) Abstract : The present invention relates to spiroazacyclic compounds as monoamine receptor<br />

modulators; compositions comprising the same; methods <strong>of</strong> inhibiting an activity <strong>of</strong> a monoamine<br />

receptor with said compounds; methods <strong>of</strong> treating a disease condition associated with a monoamine<br />

receptor using said compounds; <strong>and</strong> methods for identifying a subject suitable for treatment using said<br />

compounds.<br />

( Figure: NIL )<br />

Total Pages : 60.<br />

The Patent Office Journal <strong>24</strong>.<strong>06</strong>.<strong>2005</strong> 17927

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!